Fortis Healthcare informs about update on credit rating

27 Jul 2021 Evaluate

In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Fortis Healthcare has informed that CRISIL Ratings has upgraded Long Term Rating from ‘CRISIL A/ Watch Developing Watch Developing (continues on ‘Rating Watch with Developing Implications’)’ to ‘CRISIL A+/ Watch Developing’ for the Company and its subsidiaries, ‘Escorts Heart Institute and Research Centre, Fortis Hospotel, Fortis Hospitals and International Hospital’. Also, SRL has been assigned Long-term rating ‘CRISIL A+/ Watch Developing’ (assigned/ placed on Rating Watch with Developing Implications’). Further, the short-term rating remains same as CRISIL A1/ Watch Developing (continues on ‘Rating Watch with Developing Implications’). The detailed letters as issued by CRISIL Ratings to the Company and aforesaid subsidiaries are attached for the reference and records.

The above information is a part of company’s filings submitted to BSE.

Fortis Healthcare Share Price

677.20 -0.80 (-0.12%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.